Market Overview:
The global intelligent insulin pens market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin pens, and growing demand for smart insulin pens. Based on type, the global intelligent insulin pen market is segmented into smart Insulin pen and smart pen caps. The smart Insulin pen segment is further sub-segmented into reusable and disposable types. The disposable type is expected to account for a larger share of the global intelligent insulin pen market during the forecast period owing to its low cost and easy availability. Based on application, the global Intelligent Insulin Pen Market is segmented into home care settings, hospitals & clinics, and other applications such as research institutes & pharmaceutical companies).
Product Definition:
An intelligent insulin pen is a device that helps people with diabetes to manage their blood sugar levels. It is a sophisticated injection device that stores and delivers insulin doses according to the user's needs. The importance of an intelligent insulin pen is that it can help people with diabetes to better manage their blood sugar levels, which in turn can help to prevent serious health complications.
Smart Insulin Pen:
Smart Insulin Pen is an advanced insulin delivery device that has been designed to meet the needs of patients with diabetes. It's a portable pen-based system, which consists of a sensor and an injection port. The smart pen also comes with an application, which can be downloaded from the internet; this app helps in analyzing food intake and also provides nutrition facts along with it.
The smart insulin pens have been studied to show positive results in terms of weight loss.
Smart Pen Caps:
Smart pen caps are small plastic cartridges containing insulin and other drug formulations. They can be used in any standard or smart insulin pens. The manufacturers claim that these capsules can help in reducing human error when it comes to the dosage of drugs and also ensure better accuracy while delivering the dose.
Application Insights:
The market is segmented by application into home care settings, hospitals and clinics, and other. The home care settings segment dominated the overall market in terms of revenue share in 2017. This can be attributed to increasing awareness about the benefits of insulin therapy coupled with growing acceptance for these devices among patients suffering from diabetes at home as opposed to hospitals or clinics. Furthermore, an increase in patient visits owing to high prevalence of diabetes has also positively influenced this segment growth over the recent years.
Regional Analysis:
North America dominated the global intelligent insulin pens market in 2017. This can be attributed to the presence of major players, technological advancements, high healthcare expenditure and favorable reimbursement policies & regulatory reforms. The U.S is expected to remain a key revenue generator for this market over the forecast period due to increasing cases of diabetes and its associated complications such as kidney failure, blindness, amputations etc., which require advanced treatment with an insulin pen device that can provide fast acting Insulin delivery at home or in hospital settings along with continuous blood sugar monitoring by using disposable test strips (DBS).
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to various factors such as improving economic conditions leading towards increased disposable income resulting in increased adoption of technologically advanced medical products including smart devices for self-management of diabetes; rising awareness about new generation intelligent insulin pens; expanding distribution network set up by major players for manufacturing & selling their products through distributors;.
Growth Factors:
- Increasing prevalence of diabetes: The number of people affected by diabetes is increasing at an alarming rate across the globe. This is primarily because of changing lifestyles and dietary habits. According to the World Health Organization (WHO), the number of people with diabetes has almost quadrupled since 1980, and it is estimated that more than 422 million adults will be living with diabetes by 2030. This growing population forms a major target segment for manufacturers of intelligent insulin pens.
- Rising awareness about benefits offered by intelligent insulin pens: There is a growing awareness among diabetics about the benefits offered by intelligent insulin pens over traditional injection devices. These include features such as dose tracking, reminders to take medication, etc., which help in better management of the disease condition. This is likely to boost demand for these devices in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intelligent Insulin Pens Market Research Report
By Type
Smart Insulin Pen, Smart Pen Caps
By Application
Home Care Settings, Hospitals & Clinics, Other
By Companies
Emperra, Roche, Diamesco, Companion Medical, Patients Pending, Common Sensing, Jiangsu Delfu, Dnurse
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Intelligent Insulin Pens Market Report Segments:
The global Intelligent Insulin Pens market is segmented on the basis of:
Types
Smart Insulin Pen, Smart Pen Caps
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home Care Settings, Hospitals & Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Emperra
- Roche
- Diamesco
- Companion Medical
- Patients Pending
- Common Sensing
- Jiangsu Delfu
- Dnurse
Highlights of The Intelligent Insulin Pens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smart Insulin Pen
- Smart Pen Caps
- By Application:
- Home Care Settings
- Hospitals & Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intelligent Insulin Pens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intelligent Insulin Pens are a new type of insulin pen that uses computer algorithms to calculate the amount of insulin needed to treat diabetes. This technology is more accurate and efficient than traditional pens, which can result in lower blood sugar levels over time.
Some of the major players in the intelligent insulin pens market are Emperra, Roche, Diamesco, Companion Medical, Patients Pending, Common Sensing, Jiangsu Delfu, Dnurse.
The intelligent insulin pens market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intelligent Insulin Pens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intelligent Insulin Pens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intelligent Insulin Pens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intelligent Insulin Pens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intelligent Insulin Pens Market Size & Forecast, 2020-2028
4.5.1 Intelligent Insulin Pens Market Size and Y-o-Y Growth
4.5.2 Intelligent Insulin Pens Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Smart Insulin Pen
5.2.2 Smart Pen Caps
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Home Care Settings
6.2.2 Hospitals & Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intelligent Insulin Pens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intelligent Insulin Pens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Smart Insulin Pen
9.6.2 Smart Pen Caps
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Home Care Settings
9.10.2 Hospitals & Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Smart Insulin Pen
10.6.2 Smart Pen Caps
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Home Care Settings
10.10.2 Hospitals & Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Smart Insulin Pen
11.6.2 Smart Pen Caps
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Home Care Settings
11.10.2 Hospitals & Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Smart Insulin Pen
12.6.2 Smart Pen Caps
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Home Care Settings
12.10.2 Hospitals & Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Smart Insulin Pen
13.6.2 Smart Pen Caps
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Home Care Settings
13.10.2 Hospitals & Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intelligent Insulin Pens Market: Competitive Dashboard
14.2 Global Intelligent Insulin Pens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Emperra
14.3.2 Roche
14.3.3 Diamesco
14.3.4 Companion Medical
14.3.5 Patients Pending
14.3.6 Common Sensing
14.3.7 Jiangsu Delfu
14.3.8 Dnurse
